Position in NVS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$219,408
-$47,904 QoQ
Shares Held
1,400
-20.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#1,276
of 1,603 holders
Holding Since
Dec 2020
14 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Goepper Burkhardt LLC holds $3,500,103 across 6 Drug Manufacturers - General names. NVS ranks #6 (6.3% of the industry book) .
All Filings in NVS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $219,408 | 1,400 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $267,312 | 1,750 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $241,272 | 1,750 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $224,420 | 1,750 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $211,767 | 1,750 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $217,386 | 1,950 | Shares | Sole | 2025-05-06 | |
| 2024-09-30 | $224,289 | 1,950 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $207,597 | 1,950 | Shares | Sole | 2024-08-13 | |
| 2023-09-30 | $200,664 | 1,970 | Shares | Sole | 2023-11-13 | |
| 2022-12-31 | $204,120 | 2,250 | Shares | Sole | 2023-02-15 | |
| 2021-09-30 | $200,361 | 2,450 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $223,538 | 2,450 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $209,426 | 2,450 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $231,353 | 2,450 | Shares | Sole | 2021-02-08 | |
| No filing history on record for this holder in this stock. | ||||||